" That’s a tough question. We are getting closer and closer to developing what we call polygenic risk scores, or really just scores that include genetics and other factors. We’re much closer now than we were years ago, but to the point where it would be available for the public—I think that would be years from now. I think a lot of that is because we should be very certain what it is we’re looking at before the general public has access to it because we don’t want to make mistakes or to lead people down the wrong path, scaring them or inducing other side effects without knowing what it is we’re studying. "